January 31, 2024
(press release)
–
Kao Corporation (President: Yoshihiro Hasebe), announced today that it has entered into a definitive agreement with Kirin Beverage Company Limited (President: Toru Yoshimura), a group company of Kirin Holdings Company, Limited (President: Yoshinori Isozaki) for the transfer of Healthya, a functional tea-catechin beverage brand. About Healthya Based on years of metabolic research on body fat and visceral fat, Healthya was launched in 2003 as the first tea brand*1 claiming health promoting functionality, specifically body fat reduction, permitted for Food for Specified Health Uses, FOSHU, in Japan. Since its launch, Healthya created a new beverage market and became a long selling product with approximately 3.1 billion bottles sold to date*2 . Scope of Transaction 5 tea-catechin beverage brands; 8 product types, with FOSHU and Food with Function Claims, will be transferred to Kirin: Healthya Green Tea, Healthya Green Tea Umami Taste, Healthya Water (Sports drink), Healthya my rhythm Sparkling (Carbonated drink) and Healthya Tea Catechin Green Tea taste (Powder drink). About Kirin Dates
While Healthya has developed into an iconic brand, Kao has selected the Kirin group, a leading beverage manufacturer excelling in immunology research, as the best partner to further develop the Healthya brand.
The transfer of Healthya enables Kao to further focus its resources on strategic measures to execute its structural reformation strategy and optimize its business portfolio to achieve its mid-term plan.
Company
Kirin Holdings Company, Limited
Representative
President and CEO Yoshinori Isozaki
Head Office
Nakano Central Park South, 4-10-2 Nakano, Nakano-ku Tokyo 164-0001, Japan
Acquiring Entity
Kirin Beverage Company, Limited
Representative
President and CEO Toru Yoshimura
Office
Nakano Central Park South, 4-10-2 Nakano, Nakano-ku Tokyo 164-0001, Japan
(1) Signing
February 1st , 2024
(2) Closing
August 1st , 2024 (expected)
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
